154 related articles for article (PubMed ID: 31383943)
1. Salivary glands require Aurora Kinase B for regeneration after transient innate immune-mediated injury.
Shaalan A; Proctor G
Sci Rep; 2019 Aug; 9(1):11339. PubMed ID: 31383943
[TBL] [Abstract][Full Text] [Related]
2. Inhibitor of Aurora Kinase B Induces Differentially Cell Death and Polyploidy via DNA Damage Response Pathways in Neurological Malignancy: Shedding New Light on the Challenge of Resistance to AZD1152-HQPA.
Zekri A; Ghaffari SH; Yaghmaie M; Estiar MA; Alimoghaddam K; Modarressi MH; Ghavamzadeh A
Mol Neurobiol; 2016 Apr; 53(3):1808-1823. PubMed ID: 25752998
[TBL] [Abstract][Full Text] [Related]
3. Aurora kinase B regulates axonal outgrowth and regeneration in the spinal motor neurons of developing zebrafish.
Gwee SSL; Radford RAW; Chow S; Syal MD; Morsch M; Formella I; Lee A; Don EK; Badrock AP; Cole NJ; West AK; Cheung SNS; Chung RS
Cell Mol Life Sci; 2018 Dec; 75(23):4269-4285. PubMed ID: 29468257
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Aurora Kinase B activity disrupts development and differentiation of salivary glands.
Shaalan AK; Teshima THN; Tucker AS; Proctor GB
Cell Death Discov; 2021 Jan; 7(1):16. PubMed ID: 33462217
[TBL] [Abstract][Full Text] [Related]
5. Reactive oxygen species generation and increase in mitochondrial copy number: new insight into the potential mechanism of cytotoxicity induced by aurora kinase inhibitor, AZD1152-HQPA.
Zekri A; Mesbahi Y; Ghanizadeh-Vesali S; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
Anticancer Drugs; 2017 Sep; 28(8):841-851. PubMed ID: 28639950
[TBL] [Abstract][Full Text] [Related]
6. Epithelial disruptions, but not immune cell invasion, induced secretory dysfunction following innate immune activation in a novel model of acute salivary gland injury.
Shaalan A; Carpenter G; Proctor G
J Oral Pathol Med; 2018 Feb; 47(2):211-219. PubMed ID: 29160910
[TBL] [Abstract][Full Text] [Related]
7. Aurora kinase B inhibitor barasertib (AZD1152) inhibits glucose metabolism in gastric cancer cells.
He J; Qi Z; Zhang X; Yang Y; Liu F; Zhao G; Wang Z
Anticancer Drugs; 2019 Jan; 30(1):19-26. PubMed ID: 30540594
[TBL] [Abstract][Full Text] [Related]
8. Effects of selective inhibitors of Aurora kinases on anaplastic thyroid carcinoma cell lines.
Baldini E; Tuccilli C; Prinzi N; Sorrenti S; Antonelli A; Gnessi L; Morrone S; Moretti C; Bononi M; Arlot-Bonnemains Y; D'Armiento M; Ulisse S
Endocr Relat Cancer; 2014 Oct; 21(5):797-811. PubMed ID: 25074669
[TBL] [Abstract][Full Text] [Related]
9. Stress or injury induces cellular plasticity in salivary gland acinar cells.
Shubin AD; Sharipol A; Felong TJ; Weng PL; Schutrum BE; Joe DS; Aure MH; Benoit DSW; Ovitt CE
Cell Tissue Res; 2020 Jun; 380(3):487-497. PubMed ID: 31900666
[TBL] [Abstract][Full Text] [Related]
10. The Potential Contribution of microRNAs in Anti-cancer Effects of Aurora Kinase Inhibitor (AZD1152-HQPA).
Zekri A; Mesbahi Y; Boustanipour E; Sadr Z; Ghaffari SH
J Mol Neurosci; 2018 Aug; 65(4):444-455. PubMed ID: 30051358
[TBL] [Abstract][Full Text] [Related]
11. Significance of AZD1152 as a potential treatment against Aurora B overexpression in acute promyelocytic leukemia.
Ghanizadeh-Vesali S; Zekri A; Zaker F; Zaghal A; Yousefi M; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
Ann Hematol; 2016 Jun; 95(7):1031-42. PubMed ID: 27091351
[TBL] [Abstract][Full Text] [Related]
12. Aurora kinase B disruption suppresses pathological retinal angiogenesis by affecting cell cycle progression.
Zhu W; Gui X; Zhou Y; Gao X; Zhang R; Li Q; Zhang H; Zhao J; Cui X; Gao G; Tang H; Huan C; Pan D; Song H; Zhou Z; Shen W
Exp Eye Res; 2024 Feb; 239():109753. PubMed ID: 38142764
[TBL] [Abstract][Full Text] [Related]
13. Barasertib (AZD1152), a Small Molecule Aurora B Inhibitor, Inhibits the Growth of SCLC Cell Lines In Vitro and In Vivo.
Helfrich BA; Kim J; Gao D; Chan DC; Zhang Z; Tan AC; Bunn PA
Mol Cancer Ther; 2016 Oct; 15(10):2314-2322. PubMed ID: 27496133
[TBL] [Abstract][Full Text] [Related]
14. Co-inhibition of polo-like kinase 1 and Aurora kinases promotes mitotic catastrophe.
Li J; Hong MJ; Chow JP; Man WY; Mak JP; Ma HT; Poon RY
Oncotarget; 2015 Apr; 6(11):9327-40. PubMed ID: 25871386
[TBL] [Abstract][Full Text] [Related]
15. Inducible nitric oxide synthase-mediated injury in a mouse model of acute salivary gland dysfunction.
Shaalan A; Carpenter G; Proctor G
Nitric Oxide; 2018 Aug; 78():95-102. PubMed ID: 29885902
[TBL] [Abstract][Full Text] [Related]
16. The FLT3 internal tandem duplication mutation is a secondary target of the aurora B kinase inhibitor AZD1152-HQPA in acute myelogenous leukemia cells.
Grundy M; Seedhouse C; Shang S; Richardson J; Russell N; Pallis M
Mol Cancer Ther; 2010 Mar; 9(3):661-72. PubMed ID: 20159992
[TBL] [Abstract][Full Text] [Related]
17. Hypersensitivity to aurora kinase inhibitors in cells resistant against platinum- containing anticancer agents.
Akiyama M; Izumi H; Wang KY; Yamaguchi T; Kuma A; Kitamura N; Harada Y; Oya R; Yamaguchi K; Iwai Y; Kohno K
Anticancer Agents Med Chem; 2014; 14(7):1042-50. PubMed ID: 24521151
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of radiation response in p53-deficient cancer cells by the Aurora-B kinase inhibitor AZD1152.
Tao Y; Zhang P; Girdler F; Frascogna V; Castedo M; Bourhis J; Kroemer G; Deutsch E
Oncogene; 2008 May; 27(23):3244-55. PubMed ID: 18084327
[TBL] [Abstract][Full Text] [Related]
19. Aurora Kinase B Inhibition: A Potential Therapeutic Strategy for Cancer.
Borah NA; Reddy MM
Molecules; 2021 Apr; 26(7):. PubMed ID: 33915740
[TBL] [Abstract][Full Text] [Related]
20. Aurora Kinase B Expression, Its Regulation and Therapeutic Targeting in Human Retinoblastoma.
Borah NA; Sradhanjali S; Barik MR; Jha A; Tripathy D; Kaliki S; Rath S; Raghav SK; Patnaik S; Mittal R; Reddy MM
Invest Ophthalmol Vis Sci; 2021 Mar; 62(3):16. PubMed ID: 33704359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
